Nuvation Bio Inc. (NUVB-WT) NYSE

0.34

+0.0032(+0.96%)

Updated at December 29 03:33PM

Currency In USD

Valuation

Market Cap714.93M
Enterprise Value688.13M
P/E Ratio-14.26
PEG Ratio8.99
Price/Sales Ratio115.78
Price/Book Ratio9.52
Enterprise/Revenue112.48
Enterprise/EBITDA-13.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-8.13
Operating Margin-8.71

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.55

Income Statement

Revenue7.87M
Revenue/Share0.08
Gross Profit795,000
EBITDA-566.92M
Net Income-567.94M
Diluted EPS-2.11

Balance Sheet

Total Cash549.04M
Total Cash/Share1.6
Total Debt57.55M
Total Debt/Equity0.03
Current Ratio8.48
Book Value Per Share0.95

Price History

52-Week Change8.36
52-Week High0.4
52-Week Low0.14
Moving Average 50 Days0.23
Moving Average 200 Days0.22

Statistics

Average Volume47,197.9
Shares Outstanding342.83M
% Held by Institutions1.21

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A